Tariquidar
From Self-sufficiency
File:Tariquidar.png | |
Systematic (IUPAC) name | |
---|---|
N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide | |
Identifiers | |
CAS Number | 206873-63-4 |
ATC code | none |
PubChem | CID 148201 |
Chemical data | |
Formula | C38H38N4O6 |
Molar mass | 646.73 g/mol[[Script error: No such module "String".]] |
Tariquidar (INN/USAN) is an P-glycoprotein inhibitor[1] undergoing research for the treatment of cancer.
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol 2008;3:1302-12. PMID 18234154.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Chemotherapeutic agents
- Quinolines
- 2Fix